Anthropic CEO Dario Amodei has predicted that artificial intelligence could make it possible to cure most human diseases within five to 10 years. He acknowledged the claim may sound extraordinary even to biologists. Amodei said AI’s value will be proved by real breakthroughs against cancer and other serious illnesses rather than public-relations efforts. Former OpenAI executive Fidji Simo, now co-founder of ChronicleBio, said she disagrees with Amodei on most things but shares the view that AI’s biggest test is delivering medical results. She argued progress depends on building better biological data, not just smarter models. Cancer may be better placed for advances because of existing research data, while complex chronic diseases face larger data gaps. AI is already used to find drug targets and speed early discovery, yet lab testing, clinical trials and regulatory approval remain major hurdles. The prediction remains ambitious rather than a fixed scientific timetable.
Anthropic CEO Dario Amodei has predicted that artificial intelligence could make it possible to cure most human diseases within five to 10 years. He acknowledged the claim may sound extraordinary even to biologists. Amodei said AI’s value will be proved by real breakthroughs against cancer and other serious illnesses rather than public-relations efforts. Former OpenAI executive Fidji Simo, now co-founder of ChronicleBio, said she disagrees with Amodei on most things but shares the view that AI’s biggest test is delivering medical results. She argued progress depends on building better biological data, not just smarter models. Cancer may be better placed for advances because of existing research data, while complex chronic diseases face larger data gaps. AI is already used to find drug targets and speed early discovery, yet lab testing, clinical trials and regulatory approval remain major hurdles. The prediction remains ambitious rather than a fixed scientific timetable.